Seer

Push the Boundaries of your Proteomics Research

Seer, Inc. is driving a revolution in proteomics by removing barriers that have historically limited protein analysis. Founded in 2017 and headquartered in Redwood City, California, Seer’s mission is to enable deep, rapid, and unbiased proteomic discovery at scale. Their flagship offering—the Proteograph® Product Suite—combines engineered nanoparticles with automation instrumentation and software to provide a seamless, standardized workflow suitable for nearly any research laboratory .

By leveraging high-throughput proteome-wide analysis, Seer allows researchers to uncover biomarkers, drug targets, and disease mechanisms previously obscured by technical limitations . Strategic partnerships—such as their co‑marketing agreement with Thermo Fisher Scientific for the Orbitrap Astral mass spectrometers—underscore Seer’s commitment to broadening access to cutting-edge proteomics solutions and accelerating breakthroughs in human health.